INE-963
- Generic Name
- INE-963
Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Patients With Uncomplicated Plasmodium Falciparum Malaria
Phase 2
Recruiting
- Conditions
- Uncomplicated Plasmodium Falciparum Malaria
- Interventions
- First Posted Date
- 2023-03-02
- Last Posted Date
- 2025-03-28
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 327
- Registration Number
- NCT05750628
- Locations
- 🇺🇬
Novartis Investigative Site, Tororo, Uganda
Study of Safety, Tolerability, and Pharmacokinetics of INE963 in Healthy Participants
- First Posted Date
- 2021-05-21
- Last Posted Date
- 2023-09-28
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 64
- Registration Number
- NCT04896632
- Locations
- 🇬🇧
Novartis Investigative Site, Mere Way, Nottingham, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath